Investigating the role of Phlpp phosphatases in osteoarthritis
Phlpp phosphatases in osteoarthritis
This study is looking at how certain proteins affect joint pain and cartilage damage in people with osteoarthritis, and it aims to find new ways to help improve joint health and mobility.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10907707 on NIH RePORTER |
What this research studies
This research focuses on osteoarthritis (OA), a painful condition that leads to joint deterioration and disability. The study aims to understand how Phlpp phosphatases contribute to cartilage degradation and joint pain. By using animal models, researchers will explore the effects of inhibiting Phlpp1 and Phlpp2 on cartilage regeneration and mobility. The goal is to identify new therapeutic targets that could slow down the progression of OA and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults suffering from osteoarthritis, particularly those experiencing significant joint pain and mobility issues.
Not a fit: Patients with osteoarthritis who do not respond to current treatments or have advanced joint damage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow cartilage degradation and alleviate joint pain in osteoarthritis patients.
How similar studies have performed: Previous research has shown promise in targeting similar pathways for cartilage regeneration, indicating potential for success in this approach.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Westendorf, Jennifer J — Mayo Clinic Rochester
- Study coordinator: Westendorf, Jennifer J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.